JAIN ARJUN has a total of 14 patent applications. Its first patent ever was published in 2013. It filed its patents most often in United Kingdom, Australia and Canada. Its main competitors in its focus markets biotechnology and pharmaceuticals are APPLIED GENETIC TECH CORP, FERRUMAX PHARMACEUTICALS INC and SUNSHINE GUOJIAN PHARMACEUTICAL SHANGHAI CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United Kingdom | 7 | |
#2 | Australia | 1 | |
#3 | Canada | 1 | |
#4 | China | 1 | |
#5 | EPO (European Patent Office) | 1 | |
#6 | Singapore | 1 | |
#7 | United States | 1 | |
#8 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Therapeutic chemical compounds | |
#3 | Microorganisms | |
#4 | Medical preparations |
# | Name | Total Patents |
---|---|---|
#1 | Jain Arjun | 7 |
Publication | Filing date | Title |
---|---|---|
WO2016139543A1 | Endothelin-1 receptor based endothelin-1 sponge | |
GB201511506D0 | Tool to sequester increased endothelin-1 levels | |
GB201505993D0 | Endothelin-1 traps | |
GB201505991D0 | Endothelin-1 traps | |
GB201505914D0 | Endothelin-1 traps | |
GB201503453D0 | Endothelin-1"sponge" | |
GB201315322D0 | Endothelin-1 traps (molecular traps) |